2015 VAM: 4303 - NHLBI’s Clinical Asthma Research Network’s (AsthmaNet) Update on Answers to Key Asthma Questions
AsthmaNet is a nationwide clinical research network created by the National Heart, Lung and Blood Institute (NHLBI) in 2009. The purpose of AsthmaNet is to develop and conduct multiple clinical trials, mechanistic studies, and proof of concept studies that explore new approaches to treating asthma from childhood through adulthood. This recording discusses the results of studies to date from this effort and provides a preview of work in progress.
AMA PRA Category 1 Credits™: 1.25
Credit must be claimed by June 30, 2017. Any credit request on or after July 1, 2017 will be subject to an administrative fee.
System requirements: Two most recent versions of Internet Explorer, Safari, Google Chrome, and Firefox
Allied Health Professionals
Upon completion of this activity, participants will be able to:
1. Identify the role of azithromycin for preventing the development of upper respiratory tract illness into lower respiratory tract symptoms in children
2. Discuss challenges in determining the role of oral corticosteroids for treating episodes of significant lower respiratory tract symptoms
3. Discuss the role of vitamin D as a therapeutic agent for treating symptomatic patients with asthma and vitamin D deficiency
Dr. Leonard B. Bacharier, MD FAAAAI, Department of Pediatrics, Washington University School of Medicine and St. Louis Children’s Hospital
Dr. Theresa W. Guilbert, MD MS, Cincinnati Children's Hospital & Medical Center
Dr. Mario Castro, MD MPH, Department of Medicine, Washington University School of Medicine, Saint Louis, MO
- 1.25 AttendanceAttendance credit.
- 1.25 CECE credit.
- 1.25 CMECME credit.